Finance

Lists
Why is 4552 down 3,59%?
Dive Deeper
4552:TYO
JCR Pharmaceuticals Co Ltd
484,00 JP¥
-3,59%
(-18,00) 1D
2-окт., 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4552...
Open
499 JP¥
High
502 JP¥
Low
484 JP¥
Mkt. cap
62,77 млд
Avg. vol.
465,12 миң
Volume
576,00 миң
Dividend
4,13%
Quarterly dividend
5 JP¥
Ex-dividend date
2026-ж., 29-сен.
P/E ratio
72,19
52-wk high
824 JP¥
52-wk low
444 JP¥
EPS
7 JP¥
Shares outstanding
30,79 млн
No. of employees
985
Open
499 JP¥
High
502 JP¥
Low
484 JP¥
Mkt. cap
62,77 млд
Avg. vol.
465,12 миң
Volume
576,00 миң
Dividend
4,13%
Quarterly dividend
5 JP¥
Ex-dividend date
2026-ж., 29-сен.
P/E ratio
72,19
52-wk high
824 JP¥
52-wk low
444 JP¥
EPS
7 JP¥
Shares outstanding
30,79 млн
No. of employees
985
News stories
From web sources and news partners
About JCR Pharmaceuticals Co Ltd
CEO-
Employees985
Founded1975-ж., 13-сен.
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
12,79 млд
8,99 млд
9,97 млд
9,70 млд
Cost of goods sold
1,92 млд
2,39 млд
3,42 млд
2,25 млд
Cost of revenue
1,92 млд
2,39 млд
3,42 млд
2,25 млд
Research and development expenses
-
-
16,76 млд
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7,84 млд
8,50 млд
-10,29 млд
9,55 млд
Operating expense
7,88 млд
8,54 млд
6,48 млд
9,55 млд
Total operating expenses
9,80 млд
10,93 млд
9,90 млд
11,80 млд
Operating income
3,00 млд
-1,94 млд
66,00 млн
-2,10 млд
Other non operating income
34,00 млн
49,00 млн
-65,00 млн
135,00 млн
EBT including unusual items
3,34 млд
281,00 млн
402,00 млн
-2,08 млд
EBT excluding unusual items
3,12 млд
-1,64 млд
28,00 млн
-2,08 млд
Income tax expense
1,03 млд
157,00 млн
27,00 млн
-166,00 млн
Effective tax rate
30,79%
55,87%
6,72%
7,97%
Other operating expenses
-
-
-
-
Net income
2,29 млд
69,00 млн
399,00 млн
-1,91 млд
Net profit margin
17,92%
0,77%
4,00%
-19,66%
Earnings per share
-
-
-
-
Interest and investment income
30,00 млн
33,00 млн
27,00 млн
23,00 млн
Interest expense
-78,00 млн
-151,00 млн
-90,00 млн
-157,00 млн
Net interest expenses
-48,00 млн
-118,00 млн
-63,00 млн
-134,00 млн
Depreciation and amortization charges
39,00 млн
36,00 млн
12,00 млн
-
EBITDA
3,73 млд
-1,09 млд
705,25 млн
-1,46 млд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору